Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Ethambutol [(S,S')-2,2'-(ethylenediimino)di-1-butanol; EMB], is a first-line drug used to treat tuberculosis. To gain insight into the molecular basis of EMB resistance, we characterized the 10-kb embCAB locus in 16 EMB-resistant and 3 EMB-susceptible genetically distinct Mycobacterium tuberculosis...

Täydet tiedot

Tallennettuna:

Bibliografiset tiedot
Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Sreevatsan, S, Stockbauer, K E, Pan, X, Kreiswirth, B N, Moghazeh, S L, Jacobs, W R, Telenti, A, Musser, J M
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1997
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163984/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9257740/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.8.1677
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Samankaltaisia teoksia